Back to Search
Start Over
AHOD2131: A Randomized Phase 3 Response-Adapted Trial Comparing Standard Therapy with Immuno-Oncology Therapy for Children and Adults with Newly Diagnosed Stage I and II Classic Hodgkin Lymphoma
- Source :
- Blood; November 2023, Vol. 142 Issue: 1, Number 1 Supplement 1 p3084-3084, 1p
- Publication Year :
- 2023
-
Abstract
- Background:
Details
- Language :
- English
- ISSN :
- 00064971 and 15280020
- Volume :
- 142
- Issue :
- 1, Number 1 Supplement 1
- Database :
- Supplemental Index
- Journal :
- Blood
- Publication Type :
- Periodical
- Accession number :
- ejs64589919
- Full Text :
- https://doi.org/10.1182/blood-2023-189652